...
首页> 外文期刊>Clinical Cancer Investigation Journal >The expression level of vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, and insulin-like growth factor II mRNA binding protein 3 in renal cell carcinoma: Can these markers indicate poor prognosis in immunohistochemical examination?
【24h】

The expression level of vascular endothelial growth factor receptor-2, vascular endothelial growth factor receptor-3, and insulin-like growth factor II mRNA binding protein 3 in renal cell carcinoma: Can these markers indicate poor prognosis in immunohistochemical examination?

机译:血管内皮生长因子受体2,血管内皮生长因子受体3和胰岛素样生长因子II mRNA结合蛋白3在肾细胞癌中的表达水平:这些标志物是否可以指示免疫组织化学检查的不良预后?

获取原文
           

摘要

Background: The malignant tumors of the kidney are the most aggressive among urologic cancers. To treat patients with renal cell carcinoma (RCC), it is important to understand the disease's prognostic factors. Angiogenesis is an essential process, responsible for the growing, and spreading of neoplastic tissues. Vascular endothelial growth factor (VEGF), the most potent angiogenetic factor known, and its receptor VEGF (VEGFR) play an important role in angiogenesis. Insulin-like growth factor-II mRNA binding protein 3 (IMP-3) is found in some malignant tumors and contributes to cell growth and cell migration during the early stages of embryogenesis. Material and Methods: The following study retrospectively evaluated 48 radical, 29 simple, and 23 partial nephrectomy specimens with RCC. Pathologic prognostic parameters, including tumor size, tumor stage, Fuhrman nuclear grade, distant metastasis status, and lymph node involvement status were compared with the immunohistochemical expression levels of VEGFR-2, VEGFR-3, and IMP-3. Results: Except the relation between VEGFR-3 and Fuhrman nuclear grade, there was no significant relation with the expressions of VEGFR-2, VEGFR-3, and IMP-3 and the pathologic prognostic parameters such as tumor size, tumor stage, Fuhrman nuclear grade, distant metastasis status, and lymph node involvement status. All three markers showed significant expression in almost all chromophobe and papillary histologic subtypes. The expression rates for chromophobe, papillary type 1, and type 2 RCC were 100%, 90%, and 100% for VEGFR-2, respectively, and 87.5%, 90%, and 100% for VEGFR-3, respectively. The expression rates of IMP-3 were 50% for papillary type 1, 83.3% for papillary type 2, and 100% for chromophobe RCC. Conclusion: Although the limited number of cases, current data gathered from our study shows that these markers have no relation with pathologic prognostic parameters and would not provide additional information in the immunohistochemical examination. Anyway, their tendency of expression in chromophobe and papillary type RCC is remarkable which should be evaluated with a larger number of cases.
机译:背景:肾脏恶性肿瘤在泌尿外科癌症中最具有侵略性。要治疗肾细胞癌(RCC),重要的是要了解该病的预后因素。血管生成是必需的过程,其负责赘生性组织的生长和扩散。血管内皮生长因子(VEGF)是已知的最有效的血管生成因子,其受体VEGF(VEGFR)在血管生成中起重要作用。在某些恶性肿瘤中发现了胰岛素样生长因子-II mRNA结合蛋白3(IMP-3),在胚胎发生的早期有助于细胞生长和细胞迁移。材料和方法:以下研究回顾性评估了48例根治性,29例简单和23例部分肾切除的RCC标本。将病理预后参数,包括肿瘤大小,肿瘤分期,Fuhrman核级,远处转移状态和淋巴结受累状态与VEGFR-2,VEGFR-3和IMP-3的免疫组织化学表达水平进行了比较。结果:除VEGFR-3与Fuhrman核级之间的关系外,与VEGFR-2,VEGFR-3和IMP-3的表达以及病理学预后参数如肿瘤大小,肿瘤分期,Fuhrman核无明显关系。等级,远处转移状态和淋巴结受累状态。所有这三种标记物在几乎所有的生色团和乳头组织学亚型中均显示出显着表达。 VEGFR-2的发色团,乳头1型和2型RCC的表达率分别为VEGFR-2的100%,90%和100%,而VEGFR-3的表达率分别为87.5%,90%和100%。 IMP-3的表达率在1型乳头中为50%,在2型乳头中为83.3%,对于发色团RCC为100%。结论:尽管病例数有限,但从我们的研究中收集到的最新数据表明,这些标志物与病理预后参数无关,并且不会在免疫组织化学检查中提供其他信息。无论如何,它们在发色团和乳头状RCC中的表达趋势是显着的,应在大量病例中进行评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号